Stay updated on IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.

Latest updates to the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment is now indicated as no longer looking for participants. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0, signaling updated navigation and documentation.SummaryDifference0.4%

- Check20 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a small release update to the page's underlying versioning. This update does not alter the displayed study details.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page now shows that results were posted (May 29, 2026) with primary and secondary outcome data, along with links to sponsor information and supporting documents (protocol and statistical analysis plan).SummaryDifference3%

- Check42 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a newer build of the ClinicalTrials.gov page. This is a metadata change and does not modify the study details presented.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the clinical study record.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.5.0 (deleted) to v3.5.2 (added) for the page.SummaryDifference0.1%

Stay in the know with updates to IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.